Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dymista Safety in Children with Allergic Rhinitis
NCT01794741Phase 3Completed
- Sponsor
- Meda
- Start
- Feb 2013
- Primary completion
- Nov 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone propionate nasal spray in allergic rhinitis (AR), sponsored by Meda. Started Feb 2013; status: completed.
02
Drugs
fluticasone propionate nasal spray
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01794741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01794741.